Patents/Assignees

Optein, Inc.

1 patent in portfolio

US12612453utility2026
Method of Treating Glomerulonephritis by Administering an Antibody Which Binds and Neutralizes Human Tgf-beta1, Tgf-beta2 and Tgf-beta3
0 cites